Show item record

dc.contributor.authorRabanel, Jean-Michel
dc.contributor.authorFaivre, Jimmy
dc.contributor.authorDjiokeng Paka, Ghislain
dc.contributor.authorRamassamy, Charles
dc.contributor.authorHildgen, Patrice
dc.contributor.authorBanquy, Xavier
dc.date.accessioned2015-12-01T16:40:42Z
dc.date.availableMONTHS_WITHHELD:12fr
dc.date.available2015-12-01T16:40:42Z
dc.date.issued2015-10-01
dc.identifier.urihttp://hdl.handle.net/1866/12671
dc.subjectPoly(lactic)fr
dc.subjectPoly(ethylene glycol)fr
dc.subjectComb-polymerfr
dc.subjectNanoparticlefr
dc.subjectMicelle-likefr
dc.subjectNanoaggregatefr
dc.subjectCurcuminfr
dc.subjectToxicityfr
dc.subjectROSfr
dc.subjectCNSfr
dc.titleEffect of polymer architecture on Curcumin 1 encapsulation and release from PEGylated polymer nanoparticles: toward a drug delivery nano-platform to the CNSfr
dc.typeArticlefr
dc.contributor.affiliationUniversité de Montréal. Faculté de pharmaciefr
UdeM.statutÉtudiant(e) aux cycles supérieurs / Graduate Studentfr
dc.identifier.doi10.1016/j.ejpb.2015.09.004
dcterms.abstractWe developed a nanoparticles (NPs) library from poly(ethylene glycol)–poly lactic acid comb-like polymers with variable amount of PEG. Curcumin was encapsulated in the NPs with a view to develop a delivery platform to treat diseases involving oxidative stress affecting the CNS. We observed a sharp decrease in size between 15 and 20% w/w of PEG which corresponds to a transition from a large solid particle structure to a “micelle-like” or “polymer nano-aggregate” structure. Drug loading, loading efficacy and release kinetics were determined. The diffusion coefficients of curcumin in NPs were determined using a mathematical modeling. The higher diffusion was observed for solid particles compared to “polymer nano-aggregate” particles. NPs did not present any significant toxicity when tested in vitro on a neuronal cell line. Moreover, the ability of NPs carrying curcumin to prevent oxidative stress was evidenced and linked to polymer architecture and NPs organization. Our study showed the intimate relationship between the polymer architecture and the biophysical properties of the resulting NPs and sheds light on new approaches to design efficient NP-based drug carriers.fr
dcterms.isPartOfurn:ISSN:1873-3441
dcterms.isPartOfurn:ISSN:0939-6411
dcterms.languageengfr
UdeM.VersionRioxxVersion acceptée / Accepted Manuscript
oaire.citationTitleEuropean journal of pharmaceutics and biopharmaceutics
oaire.citationVolume96
oaire.citationStartPage409
oaire.citationEndPage420


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show item record

This document disseminated on Papyrus is the exclusive property of the copyright holders and is protected by the Copyright Act (R.S.C. 1985, c. C-42). It may be used for fair dealing and non-commercial purposes, for private study or research, criticism and review as provided by law. For any other use, written authorization from the copyright holders is required.